vs
ARDELYX, INC.（ARDX）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
PREFORMED LINE PRODUCTS CO的季度营收约是ARDELYX, INC.的1.8倍（$173.1M vs $94.5M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs -39.8%，领先44.7%），ARDELYX, INC.同比增速更快（27.5% vs 3.6%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs 10.8%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
ARDX vs PLPC — 直观对比
营收规模更大
PLPC
是对方的1.8倍
$94.5M
营收增速更快
ARDX
高出23.9%
3.6%
净利率更高
PLPC
高出44.7%
-39.8%
两年增速更快
ARDX
近两年复合增速
10.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $173.1M |
| 净利润 | $-37.6M | $8.4M |
| 毛利率 | — | 29.8% |
| 营业利润率 | — | 6.8% |
| 净利率 | -39.8% | 4.9% |
| 营收同比 | 27.5% | 3.6% |
| 净利润同比 | — | -19.3% |
| 每股收益（稀释后） | $-0.15 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXPLPC
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $173.1M | ||
| Q3 25 | $110.3M | $178.1M | ||
| Q2 25 | $97.7M | $169.6M | ||
| Q1 25 | $74.1M | $148.5M | ||
| Q4 24 | $116.1M | $167.1M | ||
| Q3 24 | $98.2M | $147.0M | ||
| Q2 24 | $73.2M | $138.7M |
净利润ARDXPLPC
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $8.4M | ||
| Q3 25 | $-969.0K | $2.6M | ||
| Q2 25 | $-19.1M | $12.7M | ||
| Q1 25 | $-41.1M | $11.5M | ||
| Q4 24 | $4.6M | $10.5M | ||
| Q3 24 | $-809.0K | $7.7M | ||
| Q2 24 | $-16.5M | $9.4M |
毛利率ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 29.8% | ||
| Q3 25 | 96.4% | 29.7% | ||
| Q2 25 | 87.3% | 32.7% | ||
| Q1 25 | 83.4% | 32.8% | ||
| Q4 24 | 84.3% | 33.3% | ||
| Q3 24 | 84.0% | 31.1% | ||
| Q2 24 | 87.1% | 31.9% |
营业利润率ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 6.8% | ||
| Q3 25 | 4.2% | 7.4% | ||
| Q2 25 | -14.7% | 10.1% | ||
| Q1 25 | -49.0% | 8.8% | ||
| Q4 24 | 7.0% | 10.5% | ||
| Q3 24 | 2.3% | 7.1% | ||
| Q2 24 | -18.6% | 8.1% |
净利率ARDXPLPC
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | 4.9% | ||
| Q3 25 | -0.9% | 1.5% | ||
| Q2 25 | -19.5% | 7.5% | ||
| Q1 25 | -55.5% | 7.8% | ||
| Q4 24 | 4.0% | 6.3% | ||
| Q3 24 | -0.8% | 5.2% | ||
| Q2 24 | -22.5% | 6.8% |
每股收益（稀释后）ARDXPLPC
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $1.72 | ||
| Q3 25 | $0.00 | $0.53 | ||
| Q2 25 | $-0.08 | $2.56 | ||
| Q1 25 | $-0.17 | $2.33 | ||
| Q4 24 | $0.01 | $2.13 | ||
| Q3 24 | $0.00 | $1.54 | ||
| Q2 24 | $-0.07 | $1.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | — |
| 总债务越低越好 | $203.5M | $38.3M |
| 股东权益账面价值 | $148.6M | $475.5M |
| 总资产 | $504.5M | $653.6M |
| 负债/权益比越低杠杆越低 | 1.37× | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ARDXPLPC
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | — | ||
| Q3 25 | $42.7M | — | ||
| Q2 25 | $90.0M | — | ||
| Q1 25 | $30.8M | — | ||
| Q4 24 | $64.9M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $41.9M | — |
总债务ARDXPLPC
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $38.3M | ||
| Q3 25 | $202.1M | $36.0M | ||
| Q2 25 | $201.4M | $31.8M | ||
| Q1 25 | $151.3M | $29.1M | ||
| Q4 24 | $150.9M | $20.8M | ||
| Q3 24 | $100.7M | $27.2M | ||
| Q2 24 | $100.2M | $31.6M |
股东权益ARDXPLPC
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $475.5M | ||
| Q3 25 | $154.3M | $466.3M | ||
| Q2 25 | $139.5M | $460.7M | ||
| Q1 25 | $145.7M | $435.8M | ||
| Q4 24 | $173.3M | $422.3M | ||
| Q3 24 | $158.3M | $429.0M | ||
| Q2 24 | $147.0M | $416.2M |
总资产ARDXPLPC
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $653.6M | ||
| Q3 25 | $486.2M | $644.6M | ||
| Q2 25 | $466.8M | $631.5M | ||
| Q1 25 | $410.2M | $592.5M | ||
| Q4 24 | $435.8M | $573.9M | ||
| Q3 24 | $367.9M | $592.0M | ||
| Q2 24 | $343.5M | $572.6M |
负债/权益比ARDXPLPC
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | 0.08× | ||
| Q3 25 | 1.31× | 0.08× | ||
| Q2 25 | 1.44× | 0.07× | ||
| Q1 25 | 1.04× | 0.07× | ||
| Q4 24 | 0.87× | 0.05× | ||
| Q3 24 | 0.64× | 0.06× | ||
| Q2 24 | 0.68× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $21.9M |
| 自由现金流经营现金流 - 资本支出 | — | $11.8M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.60× |
| 过去12个月自由现金流最近4个季度 | — | $33.3M |
8季度趋势，按日历期对齐
经营现金流ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $21.9M | ||
| Q3 25 | $365.0K | $18.9M | ||
| Q2 25 | $-25.3M | $26.9M | ||
| Q1 25 | $-38.5M | $5.7M | ||
| Q4 24 | $9.8M | $24.1M | ||
| Q3 24 | $501.0K | $9.4M | ||
| Q2 24 | $-19.4M | $28.3M |
自由现金流ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $11.8M | ||
| Q3 25 | $209.0K | $8.3M | ||
| Q2 25 | $-26.0M | $18.6M | ||
| Q1 25 | $-38.8M | $-5.3M | ||
| Q4 24 | $9.2M | $20.6M | ||
| Q3 24 | $364.0K | $5.8M | ||
| Q2 24 | $-19.5M | $24.6M |
自由现金流率ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 6.8% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | -26.6% | 10.9% | ||
| Q1 25 | -52.3% | -3.6% | ||
| Q4 24 | 7.9% | 12.3% | ||
| Q3 24 | 0.4% | 3.9% | ||
| Q2 24 | -26.7% | 17.7% |
资本支出强度ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 5.9% | ||
| Q3 25 | 0.1% | 6.0% | ||
| Q2 25 | 0.7% | 4.9% | ||
| Q1 25 | 0.4% | 7.4% | ||
| Q4 24 | 0.5% | 2.1% | ||
| Q3 24 | 0.1% | 2.4% | ||
| Q2 24 | 0.2% | 2.7% |
现金转化率ARDXPLPC
| Q1 26 | — | — | ||
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | 2.11× | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
PLPC
暂无分部数据
